Detalhe da pesquisa
1.
Sumatriptan, a serotonin 5HT1B receptor agonist, acutely reduces insulin secretion and sensitivity and glucose effectiveness in overweight humans: A double-blinded placebo-controlled cross-over trial.
Diabetes Obes Metab
; 25(10): 3059-3063, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37312648